Collegium Pharmaceutical, Inc.COLLNASDAQ
LOADING
|||
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
11.36%
↓ 66% below average
Average (39q)
33.38%
Historical baseline
Range
High:490.60%
Low:-65.30%
Volatility
1665.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 11.36% |
| Q2 2025 | 5.76% |
| Q1 2025 | -2.30% |
| Q4 2024 | 14.22% |
| Q3 2024 | 9.65% |
| Q2 2024 | 0.24% |
| Q1 2024 | -3.22% |
| Q4 2023 | 9.54% |
| Q3 2023 | 0.86% |
| Q2 2023 | -6.37% |
| Q1 2023 | 11.69% |
| Q4 2022 | 2.05% |
| Q3 2022 | 2.80% |
| Q2 2022 | 47.52% |
| Q1 2022 | 206.09% |
| Q4 2021 | -65.30% |
| Q3 2021 | -4.94% |
| Q2 2021 | -5.45% |
| Q1 2021 | 15.01% |
| Q4 2020 | -3.67% |
| Q3 2020 | 1.43% |
| Q2 2020 | 2.02% |
| Q1 2020 | 3.11% |
| Q4 2019 | 1.73% |
| Q3 2019 | -2.80% |
| Q2 2019 | 0.70% |
| Q1 2019 | 1.48% |
| Q4 2018 | 4.63% |
| Q3 2018 | -3.95% |
| Q2 2018 | 14.61% |
| Q1 2018 | 490.60% |
| Q4 2017 | -9.67% |
| Q3 2017 | 235.67% |
| Q2 2017 | 63.90% |
| Q1 2017 | 66.69% |
| Q4 2016 | 219.36% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |